A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: Analysis of clustering

Neurology

Volumn 63, Issue 11, 2004, Pages 2077-2083

  Linsell, L ^a   Cousens, S N ^a   Smith, P G ^a   Knight, R S G ^b   Zeidler, M ^b   Stewart, G ^b   De Silva, R ^b   Esmonde, T F G ^b   Ward, H J T ^b   Will, R G ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FEMALE; GENDER IDENTITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDENTIAL HOME; UNITED KINGDOM;

EID: 10444275898     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000145844.53251.BC     Document Type: Article

References (29)

1. Gibbs CJ, Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968;161:388-389.
2. Brown P. Environmental causes of human spongiform encephalopathy. In: Baker H, Ridley R, eds. Methods in molecular medicine: prion diseases. Totowa: Human Press, 1996:139-154.
3. Owen F, Poulter M, Lofthouse R, et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1989;1:51-52.
4. Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990;250:1587-1590.
5. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
6. Galvez S, Masters C, Gajdusek DC. Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile. Arch Neurol 1980;37:11-14.
7. Brown P, Cathala F, Gajdusek DC. Creutzfeldt-Jakob disease in France: III. Epidemiological study of 170 patients dying during the decade 1968-77. Ann Neurol 1979;6:438-446.
8. Davanipour Z, Alter M, Sobel E, Asher DM, Gajdusek DC. A case-control study of Creutzfeldt-Jakob disease - dietary risk factors. Am J Epidemiol 1985;122:443-451.
9. Harries-Jones R, Knight R, Will RG, Couseus S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-84: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113-1119.
10. Cousens SN, Harries-Jones R, Knight R, Will RG, Smith PG, Mathews WB. Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970-84. J Neurol Neurosurg Psychiatry 1990;53:459-465.
11. van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998;351:1081-1085.
12. Collius S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-697.
13. Ward HJT, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case control study using community controls. Neurology 2002;59:543-548.
14. Mayer V, Orolin D, Mitrova E. Cluster of Creutzfeldt-Jakob disease and presenile dementia. Lancet 1977;2:256.
15. Kahana E, Alter M, Braham J, Sofer D. Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel. Science 1974;183:90-91.
16. Goldfarb LG, Mitrova E, Brown P, Toh BH, Gajdusek DC. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 1990;336:514-515.
17. Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 1990;336:637-638.
18. Brown P, Galvez S, Goldfarb LG, et al. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 1992;112:65-67.
19. Collins S, Boyd A, Fletcher A, et al. Creutzfeldt-Jakob disease cluster in an Australian rural city. Ann Neurol 2002;52:115-118.
20. Matthews WB. Epidemiology of Creutzfeldt-Jakob disease in England and Wales. J Neurol Neurosurg Psychiatry 1975;38:210-213.
21. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235-238.
22. Huillard d'Aignaux J, Cousens SN, Delasnerie-Lauprêtre N, et al. Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int J Epidemiol 2002;31:490-495.
23. Arakawa K, Nagara H, Itoyama Y, et al. Clustering of 3 cases of Creutzfeldt-Jakob disease near Fukuoka City, Japan. Acta Neurol Scand 1991;84:445-447.
24. Farmer PM, Kane WC, Hollenberg-Sher J. Incidence of Creutzfeldt-Jakob disease in Brooklyn and Staten Island. N Engl J Med 1978;298:283-284.
25. Raubertas RF, Brown P, Cathala F, Brown I. The question of clustering of Creutzfeldt-Jakob disease. Am J Epidemiol 1989;129:146-154.
26. Rothman KJ. A sobering start to the cluster busters' conference. Am. J. Epidemiol. 1990;132(suppl 1):S6-S13.
27. Will RG. Surveillance of prion diseases in humans. In: Baker H, Ridley R, eds. Methods in molecular medicine: prion diseases. Totowa: Humana Press, 1996:119-137.
28. Pike MC, Smith PG. A case-control approach to examine diseases for evidence of contagion, including disease with long latent periods. Biometrics 1974;30:263-279.
29. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 2000;97:10248-10253.